Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014

Trends in Risk Factor Prevalence and Management Before First Stroke

(2013) Iain J. Marshall et al.   STROKE

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis

(2012) Victoria L Baczek et al.   BMC Family Practice

Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation

(2012) Francesco Dentali et al.   CIRCULATION

New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation

(2012) Jack Ansell   CIRCULATION

Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy: A qualitative meta-synthesis

(2012) Christian Borg Xuereb et al.   PATIENT EDUCATION AND COUNSELING

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

(2010) Martin J O'Donnell et al.   LANCET

Ethnic Group Disparities in 10-Year Trends in Stroke Incidence and Vascular Risk Factors

(2008) Peter U. Heuschmann et al.   STROKE